We are live on ! Find out more
NEO icon

NeoGenomics

88 hedge funds and large institutions have $175M invested in NeoGenomics in 2014 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 22 increasing their positions, 20 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

330% more call options, than puts

Call options by funds: $451K | Put options by funds: $105K

127% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 15

121% more capital invested

Capital invested by funds: $79.1M → $175M (+$95.9M)

100% more funds holding in top 10

Funds holding in top 10: 24 (+2)

28% more funds holding

Funds holding: 6988 (+19)

10% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 20

Holders
88
Holders Change
+19
Holders Change %
+27.54%
% of All Funds
2.55%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.12%
New
34
Increased
22
Reduced
20
Closed
15
Calls
$451K
Puts
$105K
Net Calls
+$346K
Net Calls Change
+$325K

NEO Hedge Fund Activity: Q3 2014 in Review

88 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q3 2014, worth a combined $175M — up 121% from $79.1M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new NEO positions and 15 closed out — a net gain of 19 holders — while 22 added to existing stakes and 20 trimmed.

The largest buyer was Driehaus Capital Management, opening a new position worth an estimated $9.96M. The largest seller was Grow Partners, cutting an estimated $6.25M.

  • 88 institutional investors held NeoGenomics (NEO) as of Q3 2014, up from 69 in Q2 2014.
  • Funds reported $175M of NeoGenomics stock for Q3 2014, up 121% quarter-over-quarter.
  • 34 funds opened new NeoGenomics positions in Q3 2014 and 15 closed out, a net change of +19 holders.
  • The largest NeoGenomics buyer in Q3 2014 was Driehaus Capital Management, an estimated $9.96M added.
  • The largest NeoGenomics seller in Q3 2014 was Grow Partners, an estimated $6.25M sold.

Based on aggregated 13F filings for Q3 2014.